Faromed Lifesciences

Faromed Lifesciences is a private specialty pharmaceutical company that markets and distributes branded niche products across multiple therapeutic segments, with a particular emphasis on gastroenterology, diabetes, cardiology, ENT, infectious disease, and OTC categories. The company presents itself as a global pharma business engaged in manufacturing, registration, marketing, export, and distribution of differentiated and in some cases under-patent products under its own brands. Its marketed portfolio includes branded products such as H-Pylomed, Farodex, Faro-Lax, Anaflex Max, and other products spanning anti-diabetic, anti-cardiac, hepatitis, antibiotics, inhalation, and topical dosage categories. Faromed states that its products are manufactured through state-of-the-art facilities with regulatory accreditations including USFDA, UKMHRA, EU GMP, WHO-GMP, and PIC/S-linked capabilities. Based on the available evidence, Faromed appears to be a commercially oriented pharma company rather than a clinical-stage biotech developer, with emphasis on product commercialization, regulatory dossiers, and global market expansion.